pharma-company /Medicinal products /Active ingredients

Rx · PZN 15638300, 16666161, 16204696

ENSPRYNG 120 mg solution for injection in a pre-filled syringe

German trade nameENSPRYNG 120 mg Injektionslösung in einer Fertigspritze

Active ingredientSatralizumabPharmaceutical formSolution for injection/infusion

Consistently available

8.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Average purchase price (B2B)

~ €14,549

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

ENSPRYNG 120 mg solution for injection in a pre-filled syringe is consistently available through wholesale. We are happy to review your purchase price and advise you on it.

Review purchasing terms

ENSPRYNG 120 mg solution for injection in a pre-filled syringe contains the active ingredient Satralizumab and comes as Solution for injection/infusion. 3 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 0.0 to 8.0 out of 10. The best-available pack was consistently available.


Pack sizes · 3 PZN

PZNIndex 7 dIndex 30 d Highest known purchase price
156383007.08.0~ €7,275
162046961.31.6~ €21,823
166661610.00.0N/A

We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.

Get in touch

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across 2 of 3 PZNs.